Role of placebo effects in pain and neuropsychiatric disorders

被引:15
作者
Belcher, Annabelle M. [1 ]
Ferre, Sergi [2 ]
Martinez, Pedro E. [3 ]
Colloca, Luana [1 ,4 ,5 ,6 ]
机构
[1] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[2] NIDA, NIH, Bethesda, MD USA
[3] NIMH, NIH, Bethesda, MD USA
[4] Univ Maryland, Sch Nursing, Dept Pain & Translat Symptom Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Anesthesiol & Psychiat, Baltimore, MD 21201 USA
[6] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA
关键词
Nocebo effect; Pharmacological and context-dependent conditioning; Verbal suggestion; Expectancy; Social observational; RANDOMIZED CONTROLLED-TRIAL; BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION; DEFICIT HYPERACTIVITY DISORDER; MAJOR DEPRESSIVE DISORDER; SUBSTANCE USE DISORDERS; OPIOID-RECEPTOR OPRM1; OPEN-LABEL PLACEBO; CLINICAL-TRIALS; NOCEBO HYPERALGESIA; ALCOHOL DEPENDENCE;
D O I
10.1016/j.pnpbp.2017.06.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The placebo (and the nocebo) effect is a powerful determinant of health outcomes in clinical disease treatment and management. Efforts to completely eradicate placebo effects have shifted dynamically, as increasingly more researchers are tuned to the potentially beneficial effects of incorporating those uncontrollable placebo effects into clinical therapeutic strategies. In this review, we highlight the major findings from placebo research, elucidating the main neurobiological systems and candidate determinants of the placebo phenomenon, and illustrate a perspective that can effectively frame future research on the topic. Finally, we issue a call for increased research on the efficacy of therapeutic strategies that incorporate placebo "tools," and argue that clinical trials of the placebo response in neuropsychiatric diseases and disorders has important and far-reaching translational and clinical relevance.
引用
收藏
页码:298 / 306
页数:9
相关论文
共 132 条
[1]   CONDITIONED ENHANCEMENT OF ANTIBODY-PRODUCTION USING ANTIGEN AS THE UNCONDITIONED STIMULUS [J].
ADER, R ;
KELLY, K ;
MOYNIHAN, JA ;
GROTA, LJ ;
COHEN, N .
BRAIN BEHAVIOR AND IMMUNITY, 1993, 7 (04) :334-343
[2]   BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION [J].
ADER, R ;
COHEN, N .
PSYCHOSOMATIC MEDICINE, 1975, 37 (04) :333-340
[3]   BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION AND MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADER, R ;
COHEN, N .
SCIENCE, 1982, 215 (4539) :1534-1536
[4]   Conditioned Pharmacotherapeutic Effects: A Preliminary Study [J].
Ader, Robert ;
Mercurio, Mary Gail ;
Walton, James ;
James, Deborra ;
Davis, Michael ;
Ojha, Valerie ;
Kimball, Alexa Boer ;
Fiorentino, David .
PSYCHOSOMATIC MEDICINE, 2010, 72 (02) :192-197
[5]   Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems [J].
Amanzio, M ;
Benedetti, F .
JOURNAL OF NEUROSCIENCE, 1999, 19 (01) :484-494
[6]  
[Anonymous], 1941, Conditioned reflexes and psychiatry
[7]   An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence [J].
Anton, Raymond F. ;
Oroszi, Gabor ;
O'Malley, Stephanie ;
Couper, David ;
Swift, Robert ;
Pettinati, Helen ;
Goldman, David .
ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (02) :135-144
[8]   Patients' Expectations Predict Surgery Outcomes: A Meta-Analysis [J].
Auer, Charlotte J. ;
Glombiewski, Julia A. ;
Doering, Bettina K. ;
Winkler, Alexander ;
Laferton, Johannes A. C. ;
Broadbent, Elizabeth ;
Rief, Winfried .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 (01) :49-62
[9]   THE POWERFUL PLACEBO [J].
BEECHER, HK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 159 (17) :1602-1606
[10]  
Belcher AM, ROUTLEDGE HDB PHILOS